{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:53:29Z","timestamp":1768992809560,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.hlc.2020.04.018","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T07:58:29Z","timestamp":1592121509000},"page":"1832-1838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel Oral Anticoagulants Compared to Warfarin for Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting"],"prefix":"10.1016","volume":"29","author":[{"given":"Kei","family":"Woldendorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Khadra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Bannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hlc.2020.04.018_bib1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejcts.2006.09.003","article-title":"Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery","volume":"30","author":"Dunning","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2020.04.018_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS Guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2020.04.018_bib3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jacc.2009.10.058","article-title":"New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft","volume":"55","author":"El-Chami","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hlc.2020.04.018_bib4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1510\/icvts.2010.243782","article-title":"Atrial fibrillation postcardiac surgery: a common but a morbid complication","volume":"12","author":"Attaran","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"10.1016\/j.hlc.2020.04.018_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ejcts\/ezx039","article-title":"Postoperative atrial fibrillation following cardiac surgery: a persistent complication","volume":"52","author":"Greenberg","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2020.04.018_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacc.2017.12.012","article-title":"New-onset atrial fibrillation after PCI or CABG for left main disease","volume":"71","author":"Kosmidou","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2020.04.018_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jama.1996.03540040044031","article-title":"Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization","volume":"276","author":"Mathew","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2020.04.018_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.athoracsur.2014.03.039","article-title":"Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs","volume":"98","author":"LaPar","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.hlc.2020.04.018_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2007.10.043","article-title":"Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery","volume":"51","author":"Echahidi","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Supplement","key":"10.1016\/j.hlc.2020.04.018_bib10","first-page":"24S","article-title":"Anticoagulation\u2217","volume":"128","author":"Epstein","year":"2015","journal-title":"Chest"},{"issue":"Supplement","key":"10.1016\/j.hlc.2020.04.018_bib11","first-page":"1S","article-title":"Executive Summary\u2217","volume":"128","author":"McKeown Peter","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2020.04.018_bib12","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2020.04.018_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2020.04.018_bib14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2020.04.018_bib15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hlc.2020.04.018_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrcardio.2017.223","article-title":"Reversal agents for non-vitamin K antagonist oral anticoagulants","volume":"15","author":"Levy","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2020.04.018_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.25475","article-title":"Reversal of direct oral anticoagulants: guidance from the anticoagulation forum","volume":"94","author":"Cuker","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hlc.2020.04.018_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/2396987319849763","article-title":"European Stroke Organisation Guideline on reversal of oral anticoagulants in acute intracerebral haemorrhage","volume":"4","author":"Christensen","year":"2019","journal-title":"Eur Stroke J"},{"issue":"7","key":"10.1016\/j.hlc.2020.04.018_bib19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/europace\/euw208","article-title":"Non-vitamin K oral anticoagulants in patients with atrial fibrillation after cardiac surgery: the results of the European Heart Rhythm Association Survey","volume":"18","author":"Vranckx","year":"2016","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.hlc.2020.04.018_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.amjsurg.2015.07.005","article-title":"Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis","volume":"210","author":"Anderson","year":"2015","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.hlc.2020.04.018_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCOUTCOMES.109.862763","article-title":"Epidemiology of subtherapeutic anticoagulation in the United States","volume":"2","author":"Rose","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.hlc.2020.04.018_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2015.03.017","article-title":"Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry","volume":"170","author":"Pokorney","year":"2015","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.hlc.2020.04.018_bib23","doi-asserted-by":"crossref","first-page":"e016980","DOI":"10.1136\/bmjopen-2017-016980","article-title":"Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada","volume":"8","author":"McAlister","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.hlc.2020.04.018_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ajh.23119","article-title":"Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study","volume":"87","author":"Dentali","year":"2012","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.hlc.2020.04.018_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH11-05-0353","article-title":"Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients","volume":"106","author":"Gallagher","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hlc.2020.04.018_bib26","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.clinthera.2014.07.016","article-title":"Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countries","volume":"36","author":"Cott\u00e9","year":"2014","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.hlc.2020.04.018_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamacardio.2016.0199","article-title":"Outcomes in a warfarin-treated population with atrial fibrillation","volume":"1","author":"Bj\u00f6rck","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.hlc.2020.04.018_bib28","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","article-title":"Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation","volume":"44","author":"Harrington","year":"2013","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.hlc.2020.04.018_bib29","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/STROKEAHA.115.012325","article-title":"Cost-effectiveness of oral anticoagulants for ischemic stroke prophylaxis among nonvalvular atrial fibrillation patients","volume":"47","author":"Shah","year":"2016","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.hlc.2020.04.018_bib30","first-page":"399","article-title":"Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US","volume":"18","author":"Amin","year":"2015","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.hlc.2020.04.018_bib31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2020.04.018_bib32","article-title":"Dabigatran Reversal with idarucizumab in patients requiring urgent surgery: a subanalysis of the RE-VERSE AD study","author":"Levy","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.hlc.2020.04.018_bib33","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1161\/CIR.0000000000000477","article-title":"Management of patients on non\u2013vitamin k antagonist oral anticoagulants in the acute care and periprocedural setting: a scientific statement from the American Heart Association","volume":"135","author":"Raval","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2020.04.018_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jocs.14054","article-title":"Impact of novel oral anticoagulants vs warfarin on effusions after coronary artery bypass grafting","volume":"34","author":"Yu","year":"2019","journal-title":"J Card Surg"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620302675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950620302675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:01:59Z","timestamp":1761415319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950620302675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1443950620302675"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2020.04.018","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Oral Anticoagulants Compared to Warfarin for Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2020.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}